AlphaGrep UK Ltd’s Chemed CHE Stock Holding History

AlphaGrep UK Ltd’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$524K	Buy	1,387 +285	+26%	+$122K	0.15%	228
2025 Q4	$472K	Buy	+1,102	New	+$480K	0.16%	230

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

AlphaGrep UK Ltd's CHE Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Chemed (CHE) stake by 26% in Q1 2026, buying an estimated $122K and bringing the position to 1,387 shares worth $524K. The position accounts for 0.15% of the portfolio, ranked #228.

AlphaGrep UK Ltd first reported a position in CHE in Q4 2025 and has held it in 2 quarters since. 491 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

AlphaGrep UK Ltd held 1,387 shares of Chemed worth $524K as of Q1 2026.
AlphaGrep UK Ltd bought 285 Chemed shares in Q1 2026, an estimated $122K.
Chemed made up 0.15% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #228 holding.
AlphaGrep UK Ltd first reported a position in Chemed in Q4 2025 and has held it in 2 quarters since.
491 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.